Ultrasonography is a widely accessible imaging technique for the detection of fatty liver, but
the reported accuracy and reliability have been inconsistent across studies. We aimed to …

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver
disease in the United States and worldwide. With obesity being an important risk factor …

Background The prognoses with respect to mortality and hepatic and nonhepatic outcomes
across the histologic spectrum of nonalcoholic fatty liver disease (NAFLD) are not well …

Context Depressive symptoms are associated with development of type 2 diabetes, but it is
unclear whether type 2 diabetes is a risk factor for elevated depressive symptoms. Objective …

Background Low-risk limits recommended for alcohol consumption vary substantially across
different national guidelines. To define thresholds associated with lowest risk for all-cause …

Previous estimates of the prevalence of nonalcoholic fatty liver disease (NAFLD) in the US
population relied on measures of liver enzymes, potentially underestimating the burden of …

Non-alcoholic fatty liver disease (NAFLD) affects 20–25% of the general population and is
associated with morbidity, increased mortality, and elevated health-care costs. Most NAFLD …

Objective To evaluate the association between non-alcoholic fatty liver disease and all
cause and cause specific mortality in a representative sample of the US general population …

OBJECTIVE Weight loss through lifestyle changes is recommended for nonalcoholic fatty
liver disease (NAFLD). However, its efficacy in patients with type 2 diabetes is unproven …

Background: Inadequate availability of healthy foods may be a barrier to achieving
recommended diets. Objective: The objective was to study the association between the …